Sale!

CRB2 Gene Ventriculomegaly with cystic kidney disease Genetic Test Cost

Name: CRB2 Gene Ventriculomegaly with cystic kidney disease Genetic Test Cost
SKU: TEST-3804
Price: 4400 AED
Availability: InStock

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “CRB2 Gene Ventriculomegaly with Cystic Kidney Disease Genetic Test” is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the CRB2 gene, which are known to cause a rare genetic disorder characterized by brain ventriculomegaly (a condition where the brain’s ventricles are abnormally enlarged) and cystic kidney disease. This test is crucial for individuals with a clinical history or family history of these conditions, providing them with a definitive diagnosis. The testing process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic mutations in the CRB2 gene. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify these mutations. Early detection through this genetic test can significantly impact the management and treatment options for affected individuals, offering them a better quality of life.

Description

CRB2 Gene Ventriculomegaly with cystic kidney disease Genetic Test

Test Name: CRB2 Gene Ventriculomegaly with cystic kidney disease Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Test Type: Hepatology Nephrology Endocrinology Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CRB2 Gene Ventriculomegaly with cystic kidney disease NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CRB2 Gene Ventriculomegaly with cystic kidney disease NGS Genetic DNA Test gene CRB2

Test Details: The CRB2 gene is associated with a genetic condition called ventriculomegaly with cystic kidney disease. This condition is characterized by the presence of enlarged ventricles in the brain (ventriculomegaly) and the development of cysts in the kidneys (cystic kidney disease). NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the context of ventriculomegaly with cystic kidney disease, NGS genetic testing can be used to identify mutations or variations in the CRB2 gene that may be responsible for the condition. By identifying the specific genetic cause of ventriculomegaly with cystic kidney disease, NGS genetic testing can help with diagnosis, provide information about the prognosis of the condition, and guide treatment decisions. It can also be useful for genetic counseling and family planning purposes, as it can determine the risk of passing the condition on to future generations.

Test Name	CRB2 Gene Ventriculomegaly with cystic kidney disease Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Hepatology Nephrology Endocrinology Disorders
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for CRB2 Gene Ventriculomegaly with cystic kidney disease NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CRB2 Gene Ventriculomegaly with cystic kidney disease NGS Genetic DNA Test gene CRB2
Test Details	The CRB2 gene is associated with a genetic condition called ventriculomegaly with cystic kidney disease. This condition is characterized by the presence of enlarged ventricles in the brain (ventriculomegaly) and the development of cysts in the kidneys (cystic kidney disease). NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the context of ventriculomegaly with cystic kidney disease, NGS genetic testing can be used to identify mutations or variations in the CRB2 gene that may be responsible for the condition. By identifying the specific genetic cause of ventriculomegaly with cystic kidney disease, NGS genetic testing can help with diagnosis, provide information about the prognosis of the condition, and guide treatment decisions. It can also be useful for genetic counseling and family planning purposes, as it can determine the risk of passing the condition on to future generations.